<!DOCTYPE html>
<!--[if IE 9]><html lang="en-US" class="no-js ie-9"> <![endif]-->
<!--[if gt IE 9]><!--> <html lang="en-US" class="no-js"><!--<![endif]-->
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=0">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<title>MoFo Life Sciences</title>
<meta name="description" itemprop="description" content>
<meta name="keywords" itemprop="keywords" content>
<link rel="canonical" href="http://lifesciences.mofo.com/">
<link rel="stylesheet" id="validate-engine-css-css" href="css/blog-validationEngine.jquery.css" type="text/css" media="all">
<link rel="stylesheet" id="fontello-css" href="css/blog-embedded.css" type="text/css" media="all">
<link rel="stylesheet" id="mofo-fonts-css" href="css/blog-fonts.css" type="text/css" media="all">
<link rel="stylesheet" id="child-normalize-css" href="css/blog-normalize.css" type="text/css" media="all">
<link rel="stylesheet" id="child-foundation-css" href="css/blog-foundation.css" type="text/css" media="all">
<link rel="stylesheet" id="child-style-css" href="css/blog-style.css" type="text/css" media="all">
<link rel="stylesheet" id="child-jetpack-css" href="css/blog-jetpack.css" type="text/css" media="all">
<link rel="stylesheet" href="css/blog-custom-style.css" type="text/css" media="all">
<link rel="stylesheet" href="css/blog-print.css" type="text/css" media="all">
<link rel="stylesheet" href="css/blog-simple-nav.css" type="text/css" media="all">
<link rel="shortcut icon" href="https://media2.mofo.com/designimages/mofo-favicon-blue-180x180-2018.png" type="image/icon">
<link rel="shortcut icon" type="image/vnd.microsoft.icon" href="favicon.ico">
<link rel="icon" href="favicon.ico" type="image/icon">
<link rel="apple-touch-icon" type="image/png" href="https://media2.mofo.com/designimages/mofo-favicon-blue-180x180-2018.png"><!-- iPhone -->
<link rel="apple-touch-icon" type="image/png" sizes="72x72" href="https://media2.mofo.com/designimages/mofo-favicon-blue-180x180-2018.png"><!-- iPad -->
<link rel="apple-touch-icon" type="image/png" sizes="114x114" href="https://media2.mofo.com/designimages/mofo-favicon-blue-180x180-2018.png"><!-- iPhone4 -->
<link rel="stylesheet" href="css/jquery-ui.css">


    <!-- Google Tag Manager -->
    <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
    new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
    j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
    'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
    })(window,document,'script','dataLayer','GTM-T8Z9VLF');</script>
    <!-- End Google Tag Manager -->


<script defer src="js/all.js" crossorigin="anonymous"></script>

<!-- Jetpack Open Graph Tags -->
<meta property="og:type" content="website">
<meta property="og:title" content="MoFo Life Sciences">
<meta property="og:description" content="Because No One is Immune to the Law">
<meta property="og:url" content="https://lifesciences.mofo.com/">
<meta property="og:site_name" content="MoFo Life Sciences">
<meta property="og:image" content="https://s0.wp.com/i/blank.jpg">
<meta property="og:locale" content="en_US">





<style>
.svg-inline--fa {

    /*height: .8em;*/

    }
.svg-inline--fa {
    width: .475em;
}
 .sd-content a.nc-facebook-circled{
     color: #3b5998;
     font-size: 30px;
     }
     .sd-content a.nc-linkedin-circled{
     color: #0077b5;
     font-size: 30px;
     }
     .sd-content a.nc-twitter-circled{
     color: #00acee;
     font-size: 30px;
     }
     .sd-content a.nc-fa-envelope-square{
     color: #034193 ;
     font-size: 30px;
     }  
     .sd-content a.nc-fa-print{
     color: #000 ;
     font-size: 30px;
     }                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
     .sd-content a hover {
     }
     .sd-content i {
      margin: -4px;
     }
     #searchsubmit {
      font-size: 1em;
      border-radius: 3px;
      font-family: 'Oswald';
      text-transform: uppercase;
      letter-spacing: 2px;
      border-style: solid;
      border-width: 0;
      font-weight: 500;
    }
</style>

<meta name="google-site-verification" content="OD6S3RPM-cQOknAs1uXmBRvRJyh28rwkOoqdes47ZUE">
</head>
<body class="home blog full-width custom-background-empty">
    <!-- Google Tag Manager (noscript) -->
    <noscript>
      <iframe src="https://www.googletagmanager.com/ns.html?id=GTM-T8Z9VLF" height="0" width="0" style="display:none;visibility:hidden"></iframe>
    </noscript>
    <!-- End Google Tag Manager (noscript) -->
    <script type="text/javascript"> 
<!-- 
var bb=new Image();var _ti=910;var _q="";var na=(navigator.appName=="Netscape");var ns=(navigator.appName.substring(0,9)=="Microsoft");var _qDate=new Date();var _r=(document.referrer.indexOf(getdomain(location))>-1?"":document.referrer);_q+="&5="+parseInt(_qDate.getTimezoneOffset());_q+="&35="+parseInt(_qDate.toString().indexOf("aylight")>-1?1:0);_q+="&6=903262831";_q+="&7=3262831";_q+="&8="+encodeURIComponent(document.location);_q+="&9="+encodeURIComponent(_r);_q+="&10="+encodeURIComponent(document.title);_q+="&11="+encodeURIComponent(navigator.userAgent);_q+="&12="+encodeURIComponent((na?navigator.language:navigator.userLanguage));_q+="&13="+((navigator.javaEnabled()?'1':'0'));if(document.cookie.indexOf("cc")==-1)document.cookie="cc=t;";_q+="&15="+((document.cookie.indexOf("cc")==-1)?"0":"1");_q+="&16="+encodeURIComponent((screen.width+'x'+screen.height));_q+="&17="+encodeURIComponent(((ns)?screen.colorDepth:screen.pixelDepth));_q+="&18="+encodeURIComponent(Math.random());_q+="&19="+_ti;bb.src="https://s.clickability.com/s?"+_q;
function setonclicks(a,b){var i=0;var retval=true;while(document.links[i]!=a){i++;}if(b.li[i])retval=b.li[i].oldonclick();bye(a);return retval;}
function newonld(){if(hasonload)oldonld();lnks=new Object();var sze=document.links.length;lnks.li=new Array(sze);for (var i=0; i<sze; i++){if(document.links[i].onclick){lnks.li[i]=document.links[i];lnks.li[i].oldonclick=document.links[i].onclick;}eval("document.links[i].onclick=function(){return setonclicks(this,lnks);}");}}function bye(a){if(a.href.toLowerCase().indexOf('http')!=0)return true;if(getdomain(location)==getdomain(a))return true;if(a.href.toLowerCase().indexOf('http')!=0)return true;var _qc="https://s.clickability.com/s?19=912";_qc+="&6=903262831";_qc+="&7=3262831";_qc+="&18="+encodeURIComponent(Math.random());_qc+="&100="+a.href;_qc+="&101="+encodeURIComponent(a.text);var cc=new Image();if(na){cc.src=_qc;pc(100);}else cc.src=_qc;return true;}function pc(a){d = new Date(); while (1){m =new Date(); df = m-d;if( df > a ) {break;}}}function getdomain(a){var i=a.host.indexOf(":");return (i>=0)?a.host.substring(0,i):a.host;}if(self['setupalready']){var dosetup = false;alert('There are two $imware.tracker calls on this page. Please alert Client Services');}else{var dosetup = true;var hasonload=false;}if(dosetup && ((window.screen)||((new Array()).toSource)||((new Array()).shift&&ns))&&(navigator.userAgent.indexOf('Mac')<0)){if(window.onload){oldonld=window.onload;hasonload=true;}window.onload=newonld;var setupalready = true;}//-->
</script><noscript>
<img alt="Clickability tracking pixel" width="1" height="1" src="https://s.clickability.com/s?19=990&amp;14=0&amp;6=903262831&amp;7=3262831&amp;25=0&amp;18=0.7933591274852008">
</noscript>

<div class="main-body-container" data-equalizer>    
<div class="nav_container">
	<a class="skip-link screen-reader-text" href="#content">Skip to content</a>  
        <div class="nav_wrap row ">
        	<div> <!-- add sticky here if needed -->
        	  <div>
                    <nav class="top-bar" data-topbar data-options="scrolltop:false;mobile_show_parent_link:false;">                  
                        <ul class="title-area">
	                        <li class="mofo-logo">
			                    <a href="https://www.mofo.com" title="Morrison & Foerster" target="_blank">
						<img src="https://media2.mofo.com/images/morrison-foerster-blog-logo.png" alt="logo">
			                    </a>
			                </li>
                            <li class="name">
                                <div class="header-title">
                                	<a href="index.html" title="MoFo Life Sciences" rel="home">
                                	                                	MoFo Life Sciences
                                	                                	</a>
                                </div>
                                                                <div class="header-subtitle">
                               		<span class="pms-7702c">Because No One is Immune to the Law</span>
                                </div>
                                                            </li>							
                            <!-- Remove the class "menu-icon" to get rid of menu icon. Take out "Menu" to just have icon alone -->
                                                    </ul>
</nav>
</div><!-- contain-to-grid sticky -->                
</div><!-- .row -->
</div>        
</div>
<!-- end .nav_container -->  


<div class="topnav" id="myTopnav">

<a href="index.html" class="active">Home</a>



<div class="divider"></div>
<div class="dropdown">

    <button class="dropbtn ">Topics 
     <i class="fa fa-caret-down"></i>
    </button>
    <div class="dropdown-content">

	
		 	<a href="topics_20.html">AI + Robotics</a>
		 	<a href="topics_5.html">Agtech</a>
		 	<a href="topics.html">Announcements</a>
		 	<a href="topics_2.html">Antitrust</a>
		 	<a href="topics_13.html">Asia</a>
		 	<a href="topics_9.html">Bioinformatics</a>
		 	<a href="topics_27.html">Biotech</a>
		 	<a href="topics_30.html">Blockchain</a>
		 	<a href="topics_6.html">CFIUS</a>
		 	<a href="topics_4.html">COVID-19</a>
		 	<a href="topics_16.html">Corporate + Venture Capital</a>
		 	<a href="topics_10.html">Data Analytics</a>
		 	<a href="topics_11.html">Digital Health</a>
		 	<a href="topics_23.html">Employment</a>
		 	<a href="topics_31.html">European Union</a>
		 	<a href="topics_18.html">FDA</a>
		 	<a href="topics_12.html">Financing</a>
		 	<a href="topics_29.html">Global</a>
		 	<a href="topics_21.html">Healthcare</a>
		 	<a href="topics_24.html">Intellectual Property</a>
		 	<a href="topics_3.html">Licensing + Commercial</a>
		 	<a href="topics_15.html">Litigation</a>
		 	<a href="topics_25.html">Medical Devices + Diagnostics</a>
		 	<a href="topics_17.html">Pharma</a>
		 	<a href="topics_19.html">Privacy + Data Security</a>
		 	<a href="topics_14.html">Product Liability + Class Action</a>
		 	<a href="topics_7.html">Rare Disease</a>
		 	<a href="topics_1.html">Regulatory</a>
		 	<a href="topics_26.html">Startup</a>
		 	<a href="topics_28.html">United Kingdom</a>
		 	<a href="topics_22.html">United States</a>
    </div>
  </div> 


<div class="divider"></div>
<a href="editors.html" class>Editors</a>


<div class="divider"></div>
<a href="about.html" class>About</a>


<div class="divider"></div>
<a href="javascript:void(0);" onclick="openSubscribeModal()" class>Subscribe</a>




<a href="javascript:void(0);" style="font-size:15px;" class="icon" onclick="myFunction()">&#9776;</a>
</div>


<div class="content_container">
    <section class="content_wrap row" role="document">
            <div id="main" role="main">
            <div class="medium-7 columns">
                <a href="welcome-to-mofo-life-sciences.html" title="Welcome to MoFo Life Sciences">
                    <img width="600" height="295" src="https://media2.mofo.com/images/life-sciences-featured-image.jpg" class="attachment-feature-image size-feature-image wp-post-image" alt>
                </a>
            </div>
            <div class="medium-5 columns">
                <div class="rockwell pms-7702c">
                   <a href="topics.html" rel="category tag">Announcements</a>
                </div>
                <h2>
                    <a href="welcome-to-mofo-life-sciences.html" title="Permalink to Welcome to MoFo Life Sciences" rel="bookmark">
                       Welcome to MoFo Life Sciences							
                    </a>
                </h2>                
                		 <p><i>MoFo Life Sciences</i> shares timely legal and business insights and in-depth analyses on trends and the complex technologies at the heart of the global pharmaceutical, biotechnology, diagnostics, medical devices, digital health, and AgTech fields.</p> 
                            </div>
            <div class="medium-12 columns">
                <hr>
            </div>
        </div>
                <div id="content" class="medium-8 large-8 columns" role="main">
        
              


    


    
<!-- #post -->          

  

 

        
            
            <article id="post-570396061" class="post-570396061 post type-post status-publish format-standard has-post-thumbnail hentry ">
                <div class="post-box">
                    <div class="row">
                                                <div class="medium-3 columns">
                            <a href="The-USPTO-says-no-to-naming-AI-as-a-patent-inventor.html" title="The USPTO Says No to Naming AI as a Patent Inventor">
                                                          <div class="attachment-thumbnail size-thumbnail wp-post-image thumb" style="background-image:url(https://media2.mofo.com/images/mofolifesciences-ai-robotics.jpg)"></div>
                                                                                        </a>
                        </div>
                        <div class="medium-9 columns">
                                                    <div class="rockwell pms-7702c">
                            <em>May 11, 2020</em>
                            - <a href="topics_8.html" rel="category tag"><a href="topics_20.html" rel="category tag">AI + Robotics</a>, <a href="topics_24.html" rel="category tag">Intellectual Property</a>, <a href="topics_22.html" rel="category tag">United States</a></a>
                        </div>
                        <h3>
                            <a href="The-USPTO-says-no-to-naming-AI-as-a-patent-inventor.html" title="Permalink to The USPTO Says No to Naming AI as a Patent Inventor" rel="bookmark">The USPTO Says No to Naming AI as a Patent Inventor</a>
                        </h3>
                        <div class="entry-meta">
                            <div class="blog-author-meta subheader">			
                                                                

                                                                By: Anna Yuan and Karen G Potter
                                                                                            </div>
                        </div>
                                                
																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																											                        <p>The increase in AI-related patent filings in the past few years has given rise to unique questions about the current patent system. In particular, the question of whether an AI system can or should be named as an inventor on a patent application has<span class="moretag">
                                <a href="The-USPTO-says-no-to-naming-AI-as-a-patent-inventor.html"> &hellip;&rsaquo;</a>
                        </span>
                        </p>
                            </div>
                        </div>
                    </div>
</article>
<!-- #post -->
            
 

                
            
            <article id="post-570317291" class="post-570317291 post type-post status-publish format-standard has-post-thumbnail hentry ">
                <div class="post-box">
                    <div class="row">
                                                <div class="medium-3 columns">
                            <a href="COVID-19-alert-FDA-updates-antibody-test-policy.html" title="COVID-19 Alert: FDA updates antibody test policy">
                                                          <div class="attachment-thumbnail size-thumbnail wp-post-image thumb" style="background-image:url(https://media2.mofo.com/images/02_28_elc_blog_600px_v216.jpg)"></div>
                                                                                        </a>
                        </div>
                        <div class="medium-9 columns">
                                                    <div class="rockwell pms-7702c">
                            <em>May 8, 2020</em>
                            - <a href="topics_8.html" rel="category tag"><a href="topics_4.html" rel="category tag">COVID-19</a>, <a href="topics_18.html" rel="category tag">FDA</a>, <a href="topics_25.html" rel="category tag">Medical Devices + Diagnostics</a>, <a href="topics_14.html" rel="category tag">Product Liability + Class Action</a>, <a href="topics_22.html" rel="category tag">United States</a></a>
                        </div>
                        <h3>
                            <a href="COVID-19-alert-FDA-updates-antibody-test-policy.html" title="Permalink to COVID-19 Alert: FDA updates antibody test policy" rel="bookmark">COVID-19 Alert: FDA updates antibody test policy</a>
                        </h3>
                        <div class="entry-meta">
                            <div class="blog-author-meta subheader">			
                                                                

                                                                By: Erin M. Bosman and Julie Y. Park
                                                                                            </div>
                        </div>
                                                
																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																									                        <p>Serology tests could play a critical role in the fight against COVID-19. Serology tests may help determine who can donate convalescent plasma&mdash;a part of the blood containing antibodies&mdash;which is currently being explored as an investigational treatment for those with COVID-19. Convalescent plasma has been<span class="moretag">
                                <a href="COVID-19-alert-FDA-updates-antibody-test-policy.html"> &hellip;&rsaquo;</a>
                        </span>
                        </p>
                            </div>
                        </div>
                    </div>
</article>
<!-- #post -->
            
 

                
            
            <article id="post-570258031" class="post-570258031 post type-post status-publish format-standard has-post-thumbnail hentry ">
                <div class="post-box">
                    <div class="row">
                                                <div class="medium-3 columns">
                            <a href="patent-offices-extend-certain-deadlines-but-proceed-with-caution.html" title="Patent Offices Extend Certain Deadlines, but Proceed With Caution">
                                                          <div class="attachment-thumbnail size-thumbnail wp-post-image thumb" style="background-image:url(https://media2.mofo.com/images/mofolifesciences-intellectual-property.jpg)"></div>
                                                                                        </a>
                        </div>
                        <div class="medium-9 columns">
                                                    <div class="rockwell pms-7702c">
                            <em>May 6, 2020</em>
                            - <a href="topics_8.html" rel="category tag"><a href="topics_4.html" rel="category tag">COVID-19</a>, <a href="topics_31.html" rel="category tag">European Union</a>, <a href="topics_24.html" rel="category tag">Intellectual Property</a>, <a href="topics_28.html" rel="category tag">United Kingdom</a>, <a href="topics_22.html" rel="category tag">United States</a></a>
                        </div>
                        <h3>
                            <a href="patent-offices-extend-certain-deadlines-but-proceed-with-caution.html" title="Permalink to Patent Offices Extend Certain Deadlines, but Proceed With Caution" rel="bookmark">Patent Offices Extend Certain Deadlines, but Proceed With Caution</a>
                        </h3>
                        <div class="entry-meta">
                            <div class="blog-author-meta subheader">			
                                                                

                                                                By: David Chan and Desmond P. O'Sullivan
                                                                                            </div>
                        </div>
                                                
																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																															                        <p>Patent applicants facing a funds shortage because of COVID-19 may be glad to hear that many patent offices have extended certain patent prosecution deadlines. For example, the U.S. Patent Office has extended various patent deadlines until June 1, 2020 and the European Patent Office<span class="moretag">
                                <a href="patent-offices-extend-certain-deadlines-but-proceed-with-caution.html"> &hellip;&rsaquo;</a>
                        </span>
                        </p>
                            </div>
                        </div>
                    </div>
</article>
<!-- #post -->
            
 

    
            
            <article id="post-570176731" class="post-570176731 post type-post status-publish format-standard has-post-thumbnail hentry ">
                <div class="post-box">
                    <div class="row">
                                                <div class="medium-3 columns">
                            <a href="CFIUS-filing-fees-become-reality.html" title="CFIUS Filing Fees Become Reality">
                                                          <div class="attachment-thumbnail size-thumbnail wp-post-image thumb" style="background-image:url(https://media2.mofo.com/images/mofolifesciences-regulatory.jpg)"></div>
                                                                                        </a>
                        </div>
                        <div class="medium-9 columns">
                                                    <div class="rockwell pms-7702c">
                            <em>May 4, 2020</em>
                            - <a href="topics_8.html" rel="category tag"><a href="topics_6.html" rel="category tag">CFIUS</a>, <a href="topics_22.html" rel="category tag">United States</a></a>
                        </div>
                        <h3>
                            <a href="CFIUS-filing-fees-become-reality.html" title="Permalink to CFIUS Filing Fees Become Reality" rel="bookmark">CFIUS Filing Fees Become Reality</a>
                        </h3>
                        <div class="entry-meta">
                            <div class="blog-author-meta subheader">			
                                                                

                                                                By: Nicholas J. Spiliotes, Charles L. Capito, Joseph A. Benkert, and Jonathan M. Babcock
                                                                                            </div>
                        </div>
                                                
																																																																																																																																																																																																																																																																																																																																																																																																																																																                        <p>The U.S. Department of the Treasury announced that on Friday, May 1, 2020, the first-ever filing fees will become effective for joint voluntary notices submitted to the Committee on Foreign Investment in the United States (CFIUS). Notices submitted to CFIUS on or after May<span class="moretag">
                                <a href="CFIUS-filing-fees-become-reality.html"> &hellip;&rsaquo;</a>
                        </span>
                        </p>
                            </div>
                        </div>
                    </div>
</article>
<!-- #post -->
            
 

            
            
            <article id="post-570945941" class="post-570945941 post type-post status-publish format-standard has-post-thumbnail hentry ">
                <div class="post-box">
                    <div class="row">
                                                <div class="medium-3 columns">
                            <a href="COVID-19-UPDATE-FDA-AUTHORIZES-FIRST-AT-HOME-COLLECTION-KIT.html" title="COVID-19 UPDATE: FDA AUTHORIZES FIRST AT-HOME COLLECTION KIT">
                                                          <div class="attachment-thumbnail size-thumbnail wp-post-image thumb" style="background-image:url(https://media2.mofo.com/images/02_28_elc_blog_600px_v216.jpg)"></div>
                                                                                        </a>
                        </div>
                        <div class="medium-9 columns">
                                                    <div class="rockwell pms-7702c">
                            <em>May 1, 2020</em>
                            - <a href="topics_8.html" rel="category tag"><a href="topics_4.html" rel="category tag">COVID-19</a>, <a href="topics_18.html" rel="category tag">FDA</a>, <a href="topics_14.html" rel="category tag">Product Liability + Class Action</a>, <a href="topics_22.html" rel="category tag">United States</a></a>
                        </div>
                        <h3>
                            <a href="COVID-19-UPDATE-FDA-AUTHORIZES-FIRST-AT-HOME-COLLECTION-KIT.html" title="Permalink to COVID-19 UPDATE: FDA AUTHORIZES FIRST AT-HOME COLLECTION KIT" rel="bookmark">COVID-19 UPDATE: FDA AUTHORIZES FIRST AT-HOME COLLECTION KIT</a>
                        </h3>
                        <div class="entry-meta">
                            <div class="blog-author-meta subheader">			
                                                                

                                                                By: Erin M. Bosman and Julie Y. Park
                                                                                            </div>
                        </div>
                                                
																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					                        <p>FDA has been actively working to accelerate access to diagnostic tests for COVID-19 through its extension of Emergency Use Authorizations (EUAs). According to FDA Commissioner Stephen M. Hahn, M.D., &ldquo;The FDA&rsquo;s around-the-clock work since this outbreak began has resulted in the authorization of more<span class="moretag">
                                <a href="COVID-19-UPDATE-FDA-AUTHORIZES-FIRST-AT-HOME-COLLECTION-KIT.html"> &hellip;&rsaquo;</a>
                        </span>
                        </p>
                            </div>
                        </div>
                    </div>
</article>
<!-- #post -->
            
 

    
            
            <article id="post-570299121" class="post-570299121 post type-post status-publish format-standard has-post-thumbnail hentry ">
                <div class="post-box">
                    <div class="row">
                                                <div class="medium-3 columns">
                            <a href="COVID-19-excusing-performance-using-force-majeure-clauses-under-Japanese-law.html" title="COVID-19: Excusing Performance Using Force Majeure Clauses Under Japanese Law">
                                                          <div class="attachment-thumbnail size-thumbnail wp-post-image thumb" style="background-image:url(https://media2.mofo.com/images/mofolifesciences-japan.jpg)"></div>
                                                                                        </a>
                        </div>
                        <div class="medium-9 columns">
                                                    <div class="rockwell pms-7702c">
                            <em>April 30, 2020</em>
                            - <a href="topics_8.html" rel="category tag"><a href="topics_13.html" rel="category tag">Asia</a>, <a href="topics_4.html" rel="category tag">COVID-19</a></a>
                        </div>
                        <h3>
                            <a href="COVID-19-excusing-performance-using-force-majeure-clauses-under-Japanese-law.html" title="Permalink to COVID-19: Excusing Performance Using Force Majeure Clauses Under Japanese Law" rel="bookmark">COVID-19: Excusing Performance Using Force Majeure Clauses Under Japanese Law</a>
                        </h3>
                        <div class="entry-meta">
                            <div class="blog-author-meta subheader">			
                                                                

                                                                By: Chie Yakura and Yukihiro Terazawa
                                                                                            </div>
                        </div>
                                                
																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			                        <p>On April 7, 2020, Prime Minister Shinzo Abe declared a state of emergency in response to the spread of COVID19. As a result, an increasing number of businesses are unable to continue operating and are having difficulty performing their contractual obligations. Their business partners<span class="moretag">
                                <a href="COVID-19-excusing-performance-using-force-majeure-clauses-under-Japanese-law.html"> &hellip;&rsaquo;</a>
                        </span>
                        </p>
                            </div>
                        </div>
                    </div>
</article>
<!-- #post -->
            
 

                
            
            <article id="post-569996381" class="post-569996381 post type-post status-publish format-standard has-post-thumbnail hentry ">
                <div class="post-box">
                    <div class="row">
                                                <div class="medium-3 columns">
                            <a href="mental-health-during-COVID-19-FDA-waivers-for-digital-health-devices.html" title="Mental Health during COVID-19: FDA Waivers for Digital Health Devices">
                                                          <div class="attachment-thumbnail size-thumbnail wp-post-image thumb" style="background-image:url(https://media2.mofo.com/images/02_28_elc_blog_600px_v216.jpg)"></div>
                                                                                        </a>
                        </div>
                        <div class="medium-9 columns">
                                                    <div class="rockwell pms-7702c">
                            <em>April 27, 2020</em>
                            - <a href="topics_8.html" rel="category tag"><a href="topics_4.html" rel="category tag">COVID-19</a>, <a href="topics_18.html" rel="category tag">FDA</a>, <a href="topics_21.html" rel="category tag">Healthcare</a>, <a href="topics_25.html" rel="category tag">Medical Devices + Diagnostics</a>, <a href="topics_22.html" rel="category tag">United States</a></a>
                        </div>
                        <h3>
                            <a href="mental-health-during-COVID-19-FDA-waivers-for-digital-health-devices.html" title="Permalink to Mental Health during COVID-19: FDA Waivers for Digital Health Devices" rel="bookmark">Mental Health during COVID-19: FDA Waivers for Digital Health Devices</a>
                        </h3>
                        <div class="entry-meta">
                            <div class="blog-author-meta subheader">			
                                                                

                                                                By: Jean Nguyen
                                                                                            </div>
                        </div>
                                                
																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																									                        <p>As the number of days during which the U.S. remains under stay-at-home orders increases, the mental health of individuals has become a growing concern.  Last week, the U.S. Food and Drug Administration (FDA) announced temporarily waiving certain requirements for digital health devices for<span class="moretag">
                                <a href="mental-health-during-COVID-19-FDA-waivers-for-digital-health-devices.html"> &hellip;&rsaquo;</a>
                        </span>
                        </p>
                            </div>
                        </div>
                    </div>
</article>
<!-- #post -->
            
 

                            
            
            <article id="post-569858531" class="post-569858531 post type-post status-publish format-standard has-post-thumbnail hentry ">
                <div class="post-box">
                    <div class="row">
                                                <div class="medium-3 columns">
                            <a href="FDA-uses-EUAs-broadly-in-the-fight-against-Covid-19.html" title="FDA Uses EUAs Broadly In The Fight Against Covid-19">
                                                          <div class="attachment-thumbnail size-thumbnail wp-post-image thumb" style="background-image:url(https://media2.mofo.com/images/02_28_elc_blog_600px_v216.jpg)"></div>
                                                                                        </a>
                        </div>
                        <div class="medium-9 columns">
                                                    <div class="rockwell pms-7702c">
                            <em>April 22, 2020</em>
                            - <a href="topics_8.html" rel="category tag"><a href="topics_27.html" rel="category tag">Biotech</a>, <a href="topics_4.html" rel="category tag">COVID-19</a>, <a href="topics_18.html" rel="category tag">FDA</a>, <a href="topics_21.html" rel="category tag">Healthcare</a>, <a href="topics_25.html" rel="category tag">Medical Devices + Diagnostics</a>, <a href="topics_17.html" rel="category tag">Pharma</a>, <a href="topics_14.html" rel="category tag">Product Liability + Class Action</a>, <a href="topics_22.html" rel="category tag">United States</a></a>
                        </div>
                        <h3>
                            <a href="FDA-uses-EUAs-broadly-in-the-fight-against-Covid-19.html" title="Permalink to FDA Uses EUAs Broadly In The Fight Against Covid-19" rel="bookmark">FDA Uses EUAs Broadly In The Fight Against Covid-19</a>
                        </h3>
                        <div class="entry-meta">
                            <div class="blog-author-meta subheader">			
                                                                

                                                                By: Julie Y. Park
                                                                                            </div>
                        </div>
                                                
																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																											                        <p>On February 4, 2020, the Secretary of the Department of Health and Human Services (HHS) determined, pursuant to section 564 of the Federal Food, Drug and Cosmetic (FD&amp;C) Act, that there is a significant potential for a public health emergency related to the novel<span class="moretag">
                                <a href="FDA-uses-EUAs-broadly-in-the-fight-against-Covid-19.html"> &hellip;&rsaquo;</a>
                        </span>
                        </p>
                            </div>
                        </div>
                    </div>
</article>
<!-- #post -->
            
 

            
            
            <article id="post-569830941" class="post-569830941 post type-post status-publish format-standard has-post-thumbnail hentry ">
                <div class="post-box">
                    <div class="row">
                                                <div class="medium-3 columns">
                            <a href="HHS-guidance-broadens-PREP-act-immunity-tightens-focus-on-public-private-cooperation.html" title="HHS Guidance Broadens PREP Act Immunity, Tightens Focus on Public/Private Cooperation">
                                                          <div class="attachment-thumbnail size-thumbnail wp-post-image thumb" style="background-image:url(https://media2.mofo.com/images/02_28_elc_blog_600px_v216.jpg)"></div>
                                                                                        </a>
                        </div>
                        <div class="medium-9 columns">
                                                    <div class="rockwell pms-7702c">
                            <em>April 21, 2020</em>
                            - <a href="topics_8.html" rel="category tag"><a href="topics_4.html" rel="category tag">COVID-19</a>, <a href="topics_18.html" rel="category tag">FDA</a>, <a href="topics_21.html" rel="category tag">Healthcare</a>, <a href="topics_14.html" rel="category tag">Product Liability + Class Action</a></a>
                        </div>
                        <h3>
                            <a href="HHS-guidance-broadens-PREP-act-immunity-tightens-focus-on-public-private-cooperation.html" title="Permalink to HHS Guidance Broadens PREP Act Immunity, Tightens Focus on Public/Private Cooperation" rel="bookmark">HHS Guidance Broadens PREP Act Immunity, Tightens Focus on Public/Private Cooperation</a>
                        </h3>
                        <div class="entry-meta">
                            <div class="blog-author-meta subheader">			
                                                                

                                                                By: Erin M. Bosman and Julie Y. Park
                                                                                            </div>
                        </div>
                                                
																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																											                        <p>On April 14, the U.S. Department of Health and Human Services (HHS) issued an advisory opinion on the Public Readiness and Emergency Preparedness (PREP) Act to clarify the scope of immunity that accompanies developing and deploying countermeasures to COVID-19.

The PREP Act grants tort liability<span class="moretag">
                                <a href="HHS-guidance-broadens-PREP-act-immunity-tightens-focus-on-public-private-cooperation.html"> &hellip;&rsaquo;</a>
                        </span>
                        </p>
                            </div>
                        </div>
                    </div>
</article>
<!-- #post -->
            
 

        
            
            <article id="post-569823581" class="post-569823581 post type-post status-publish format-standard has-post-thumbnail hentry ">
                <div class="post-box">
                    <div class="row">
                                                <div class="medium-3 columns">
                            <a href="Morrison-Foerster-expands-corporate-capabilities-adding-new-corporate-co-chair-Mitchell-Presser.html" title="Morrison & Foerster Expands Corporate Capabilities Adding New Corporate Co-Chair Mitchell Presser">
                                                          <div class="attachment-thumbnail size-thumbnail wp-post-image thumb" style="background-image:url(https://media2.mofo.com/images/presser_mitchell_social_600x600.jpg)"></div>
                                                                                        </a>
                        </div>
                        <div class="medium-9 columns">
                                                    <div class="rockwell pms-7702c">
                            <em>April 20, 2020</em>
                            - <a href="topics_8.html" rel="category tag"><a href="topics_5.html" rel="category tag">Agtech</a>, <a href="topics.html" rel="category tag">Announcements</a>, <a href="topics_16.html" rel="category tag">Corporate + Venture Capital</a></a>
                        </div>
                        <h3>
                            <a href="Morrison-Foerster-expands-corporate-capabilities-adding-new-corporate-co-chair-Mitchell-Presser.html" title="Permalink to Morrison & Foerster Expands Corporate Capabilities Adding New Corporate Co-Chair Mitchell Presser" rel="bookmark">Morrison & Foerster Expands Corporate Capabilities Adding New Corporate Co-Chair Mitchell Presser</a>
                        </h3>
                        <div class="entry-meta">
                            <div class="blog-author-meta subheader">			
                                                                

                                                                By: Mitchell S. Presser
                                                                                            </div>
                        </div>
                                                
																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																													                        <p>Morrison &amp; Foerster is pleased to announce the continued expansion of its New York office and global Corporate Department capabilities with the arrival of corporate partner Mitchell Presser. He joins the firm as a partner in its Mergers + Acquisitions and Private Equity Investments<span class="moretag">
                                <a href="Morrison-Foerster-expands-corporate-capabilities-adding-new-corporate-co-chair-Mitchell-Presser.html"> &hellip;&rsaquo;</a>
                        </span>
                        </p>
                            </div>
                        </div>
                    </div>
</article>
<!-- #post -->
                        <ul class="pagination clearfix">
                <li class></li>
             

                        
                                                

                <li><a href="index_14.html">« Previous</a></li>
                                
                                    <li><a href="index_3.html">9</a>
                        </li>
                                    <li><a href="index_5.html">10</a>
                        </li>
                                    <li><a href="index_10.html">11</a>
                        </li>
                                    <li><a href="index_14.html">12</a>
                        </li>
                                    <li class="current"><a href="#">13</a>
                        </li>
                                    <li><a href="index_12.html">14</a>
                        </li>
                                    <li><a href="index_15.html">15</a>
                        </li>
                                    <li><a href="index_16.html">16</a>
                        </li>
                                    <li><a href="index_17.html">17</a>
                        </li>
                                    <li><a href="index_19.html">18</a>
                        </li>
                 
                <li><a href="index_12.html">  Next.</a></li>
                        
                                                
             
                <li class></li>
            </ul>
                </div>
                <!-- #content -->
                <div id="secondary" class="medium-4 large-4 columns widget-area data-equalizer-watch" role="complementary">
                        

<aside id="black-studio-tinymce-3" class="widget widget_black_studio_tinymce">
    <div class="textwidget">
        <div class="gray-sidebar">
            <h5>Stay Connected </h5>
                                        <a title="Connect via LinkedIn" class="nc-linkedin-circled" href="https://www.linkedin.com/company/morrison-&amp;-foerster-llp" target="_blank">
                        <i class="icon-linkedin-circled footer-icons black85"></i>
                    </a>
                                        <a title="Connect via Twitter" class="nc-twitter-circled" href="https://twitter.com/MoFoLLP" target="_blank">
                        <i class="icon-twitter-circled footer-icons black85"></i>
                    </a>
                                        <a title="Connect via RSS" class="nc-rss" href="rss" target="_blank">
                        <i class="icon-rss footer-icons black85"></i>
                    </a>
                            </div>
    </div>
</aside>
<aside id="search-2" class="widget widget_search">
    <form role="search" method="get" id="searchform" action="/search/">
        <div class="row collapse">
            <div class="medium-12 large-12 columns">
                <input type="text" value name="s" id="s">
                    <div class="search-icon">
                        <i class="icon-search footer-icons pms-7702c"></i>
                    </div>
                    <input type="submit" id="searchsubmit" value="Search" class="search-btn">
                    </div>
</div>
</form>
</aside>
<aside id="categories-2" class="widget widget_categories">
    <h6 class="widget-title">Topics</h6>
            <label class="screen-reader-text" for="cat">Topics</label>
            <select name="cat" id="cat" class="postform">
                <option value="-1">Topics</option>
                                                                                                                                                <option class="level-0" value="1457511">AI + Robotics</option>
                                                                                                <option class="level-0" value="1457521">Agtech</option>
                                                                                                <option class="level-0" value="1457691">Announcements</option>
                                                                                                <option class="level-0" value="1462201">Antitrust</option>
                                                                                                <option class="level-0" value="1457531">Asia</option>
                                                                                                <option class="level-0" value="1468521">Bioinformatics</option>
                                                                                                <option class="level-0" value="1456751">Biotech</option>
                                                                                                <option class="level-0" value="1458171">Blockchain</option>
                                                                                                <option class="level-0" value="1458511">CFIUS</option>
                                                                                                <option class="level-0" value="1462211">COVID-19</option>
                                                                                                <option class="level-0" value="1457541">Corporate + Venture Capital</option>
                                                                                                <option class="level-0" value="1458861">Data Analytics</option>
                                                                                                <option class="level-0" value="1465651">Digital Health</option>
                                                                                                <option class="level-0" value="1458521">Employment</option>
                                                                                                <option class="level-0" value="1457551">European Union</option>
                                                                                                <option class="level-0" value="1459381">FDA</option>
                                                                                                <option class="level-0" value="1457561">Financing</option>
                                                                                                <option class="level-0" value="1459511">Global</option>
                                                                                                <option class="level-0" value="1459951">Healthcare</option>
                                                                                                <option class="level-0" value="1457581">Intellectual Property</option>
                                                                                                <option class="level-0" value="1457591">Licensing + Commercial</option>
                                                                                                <option class="level-0" value="1457601">Litigation</option>
                                                                                                <option class="level-0" value="1459061">Medical Devices + Diagnostics</option>
                                                                                                <option class="level-0" value="1457631">Pharma</option>
                                                                                                <option class="level-0" value="1457641">Privacy + Data Security</option>
                                                                                                <option class="level-0" value="1457651">Product Liability + Class Action</option>
                                                                                                <option class="level-0" value="1465361">Rare Disease</option>
                                                                                                <option class="level-0" value="1459071">Regulatory</option>
                                                                                                <option class="level-0" value="1459521">Startup</option>
                                                                                                <option class="level-0" value="1462611">United Kingdom</option>
                                                                                                <option class="level-0" value="1457671">United States</option>
                                                            </select>
            <script type="text/javascript">
                /* <![CDATA[ */
                (function() {
                var dropdown = document.getElementById( "cat" );
                function onCatChange() {
                if ( dropdown.options[ dropdown.selectedIndex ].value > 0 ) {
                location.href = "/topics/?c=" + dropdown.options[ dropdown.selectedIndex ].value;
                }
                }
                dropdown.onchange = onCatChange;
                })();
                /* ]]> */
            </script>
</aside>
<aside id="text-2" class="widget widget_text">
<h6 class="widget-title"></h6>
<h5>Subscribe</h5>
<p>Never miss a post from MoFo Life Sciences. Enter your email below to stay up-to-date.</p>
<iframe src="https://www2.mofo.com/l/323401/2020-09-03/621wk" width="100%" height="450" type="text/html" frameborder="0" allowtransparency="true" style="border: 0;"></iframe>
<h6 class="widget-title"></h6>
<h5>Resources</h5>
<ul>
<li><a href="https://www.mofo.com/capabilities/life-sciences-healthcare.html" target="_blank">Life Sciences and Healthcare Group</a></li>
<li><a href="https://www.mofo.com/special-content/life-sciences-podcast.html" target="_blank">Life Sciences Podcast</a></li>
<li><a target="_blank" href="https://www.mofo.com/capabilities/patent-counseling-prosecution.html">Patent Counseling + Prosecution</a></li>
<li><a target="_blank" href="https://www.mofo.com/capabilities/fda-life-sciences-compliance.html">FDA Regulatory + Life Sciences Compliance</a></li>
<li><a target="_blank" href="https://www.mofo.com/capabilities/life-sciences-transactions-licensing.html">Life Sciences Transactions + Licensing</a></li>
</ul>
<h6 class="widget-title"></h6>
<h5>Editors</h5>
<div class="text-center"><img alt="Wolfgang Shonig" src="https://media2.mofo.com/images/schonig_wolfgang_blog_150x150.png" scale="0"></div>
<h5 class="text-center">Wolfgang Sch&ouml;nig</h5>
<div class="rockwell text-center subheader">Partner</div>
<p class="bio">Wolfgang Sch&ouml;nig advises clients on IP aspects relating to transactions in, among others, the life sciences, AgTech and pharmaceuticals industry, as well as legal representation in IP disputes. His additional focus areas include research and development collaborations, complex licensing agreements, technology acquisitions, know-how protection strategies, and employee invention law. <a href="https://www.mofo.com/people/wolfgang-schonig.html" target="_blank">More &rsaquo;</a></p>
<div class="text-center"><img alt="Anita Choi" src="https://media2.mofo.com/images/choi_anita_blog_150x150.png" scale="0"></div>
<h5 class="text-center">Anita Choi</h5>
<div class="rockwell text-center subheader">Partner</div>
<p class="bio">Anita Choi&rsquo;s practice focuses on patent prosecution, portfolio management, IP due diligence, and IP litigation support. Her clients range from early-stage start-up enterprises to established domestic and international companies. She is well-versed in building and managing worldwide patent portfolios across many sectors and technologies, including small-molecule pharmaceuticals, medical devices, diagnostics, industrial chemicals and advanced materials, food and agtech. <a href="https://www.mofo.com/people/anita-choi.html" target="_blank">More &rsaquo;</a></p>
<div class="text-center"><img alt="Stacy Amin" src="https://media2.mofo.com/images/amin_stacy_blog_150x150.png" scale="0"></div>
<h5 class="text-center">Stacy Amin</h5>
<div class="rockwell text-center subheader">Partner</div>
<p class="bio">Stacy Cline Amin leads the FDA Regulatory &amp; Compliance practice within the firm&rsquo;s Global Life Sciences + Healthcare Group and provides strategic regulatory and business advice to companies in the life sciences, healthcare, and technology industries. Stacy previously served as Chief Counsel of the U.S. Food and Drug Administration (FDA) and Deputy General Counsel of the Department of Health and Human Services (HHS), and held senior positions within the White House Counsel&rsquo;s Office and health committees in both the House and Senate. With her depth of experience across government agencies, she provides clients with an insider&rsquo;s perspective on regulatory and compliance issues, enforcement actions, and litigation challenges. <a href="https://www.mofo.com/people/stacy-amin.html" target="_blank"> More &rsaquo;</a></p>
</aside>
<aside class="widget widget_recent_entries">
    <h6 class="widget-title">Recent Posts</h6>
            <ul>
                                                    <li>
                        <a href="eu-in-vitro-diagnostic-regulation-entered-into-force-part-3-of-3.html">EU: IN VITRO DIAGNOSTIC REGULATION ENTERED INTO FORCE (PART 3 OF 3)</a>
                    </li>
                                                                    <li>
                        <a href="fda-will-once-again-accept-pre-submissions-for-all-in-vitro-diagnostic-tests.html">FDA Will Once Again Accept Pre-Submissions for All In Vitro Diagnostic Tests</a>
                    </li>
                                                                    <li>
                        <a href="eu-in-vitro-diagnostic-regulation-entered-into-force--part-2-of-3.html">EU: IN VITRO DIAGNOSTIC REGULATION ENTERED INTO FORCE  (PART 2 OF 3) </a>
                    </li>
                                                                    <li>
                        <a href="eu-in-vitro-diagnostic-regulation-entered-into-force--part-1-of-3.html">EU: IN VITRO DIAGNOSTIC REGULATION ENTERED INTO FORCE  (PART 1 OF 3) </a>
                    </li>
                                                                    <li>
                        <a href="senators-call-for-report-on-state-of-psychedelic-research.html">Senators Call for Report on State of Psychedelic Research</a>
                    </li>
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            </ul>
</aside>
<aside id="black-studio-tinymce-6" class="widget widget_black_studio_tinymce">
     <style>

address {
  font-style: normal;
  margin-bottom: 14px;
  margin-left: 10px;
}

address .contact  {
  display: block;
  
}

address .email a:hover {
  color: #0078a0;
}

.location, .attorney, .email {
  display: block;

}

address .email a {
color: #5e5f61;
}

.location {
  font-weight: 900;
  font-family: 'Oswald', sans-serif;
  text-transform: uppercase;
}

.contact-title {
  font-family: 'Oswald', sans-serif;
  font-size: .825em;
  background-color: #eeeeee;
  padding: .8em;
  letter-spacing: 2px;
  text-transform: uppercase;
  margin-bottom: 10px;
  display: block;
  font-weight: 900;
}

</style>

  


</aside>
                </div>
<!-- #secondary -->
</section>
<!-- end .content-wrap -->
                    </div>
                    <!-- end .content_container -->
                    <div style="display:none;" id="dialog-message" title="Email Disclaimer">
	<p>Unsolicited e-mails and information sent to Morrison &amp; Foerster will not be considered confidential, may be disclosed to others pursuant to our Privacy Policy, may not receive a response, and do not create an attorney-client relationship with Morrison &amp; Foerster. If you are not already a client of Morrison &amp; Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.</p>
</div>
<div class="footer_container">
    <footer class="footer_wrap row" role="contentinfo">
        <div id="footer" class="row" role="contentinfo">
            <div class="columns medium-12 footer-nav-wrapper">
                <div class="footer-nav">
                    <ul>
                                                <li class="divider"></li>
                        <li id="menu-item-3395" class="menu-item menu-item-footer menu-item-terms-of-use">
                            <a target="_blank" href="https://www.mofo.com/about/terms-notices.html">Terms of Use</a>
                        </li>
                                                <li class="divider"></li>
                        <li id="menu-item-3395" class="menu-item menu-item-footer menu-item-cookies">
                            <a target="_blank" href="https://www.mofo.com/about/cookies.html">Cookies</a>
                        </li>
                                                <li class="divider"></li>
                        <li id="menu-item-3395" class="menu-item menu-item-footer menu-item-privacy-policy">
                            <a target="_blank" href="https://www.mofo.com/about/privacy-policy.html">Privacy Policy</a>
                        </li>
                                                <li class="divider"></li>
                        <li id="menu-item-3395" class="menu-item menu-item-footer menu-item-disclaimer">
                            <a target="_blank" href="https://www.mofo.com/special-content/blog-disclaimer/">Disclaimer</a>
                        </li>
                                                <li class="divider"></li>
                        <li id="menu-item-3395" class="menu-item menu-item-footer menu-item-attorney-advertising">
                            <a target="_blank" href="https://www.mofo.com/about/attorney-advertising.html">Attorney Advertising</a>
                        </li>
                        </ul></div>
                </div>
                <div class="columns medium-12 text-center">
                    <p class="copyright">&copy;1996-2022 Morrison &amp; Foerster LLP. <span class="show-for-small"><br></span>All Rights Reserved.</p>
                </div>
                <div class="medium-2 medium-centered columns">
                                                            <a title="Connect via LinkedIn" class="nc-linkedin" href="https://www.linkedin.com/company/morrison-&amp;-foerster-llp" target="_blank">
                        <i class="icon-linkedin-circled footer-icons pms-7702c"></i>
                    </a>
                                                            <a title="Connect via Twitter" class="nc-twitter" href="https://twitter.com/MoFoLLP" target="_blank">
                        <i class="icon-twitter-circled footer-icons pms-7702c"></i>
                    </a>
                                                            <a title="Connect via RSS" class="nc-rss" href="rss" target="_blank">
                        <i class="icon-rss footer-icons pms-7702c"></i>
                    </a>
                                    </div>
                                            </div>
</footer>
<!-- .row -->
</div>
<!-- end #footer_container -->
<div id="backtotop" class="hvr-fade">
    <span class="genericon genericon-collapse"></span>
</div>
<!-- #backtotop -->

</div>
     <div class="textwidget">
        <div id="subscribe-modal" class="reveal-modal" data-reveal aria-labelledby="subscribe-modal" aria-hidden="true" role="dialog">
            <aside class="widget widget_black_studio_tinymce">
                <div class="textwidget newsletter_subscribe">
                    <div>
                        <h5>Subscribe</h5>
                                <p>Never miss a post from MoFo Life Sciences. Enter your email below to stay up-to-date.</p>
                    </div>
                </div>
                            </aside>
            <p>
                <div class="resultLabel"></div>
                <div class="widget_wysija_cont shortcode_wysija newsletter_subscribe">
                                   <iframe src="https://www2.mofo.com/l/323401/2020-09-03/621wk" width="100%" height="450" type="text/html" frameborder="0" allowTransparency="true" style="border: 0"></iframe>
                                                </div>
                    <a class="close-reveal-modal" onClick="closeSubscriptionModal()" aria-label="Close"></a>
</p></div>
</div>



<script>
  (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
  (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
  m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
  })(window,document,'script','https://www.google-analytics.com/analytics.js','ga');
  ga('create', 'UA-12456654-15', 'auto');   ga('send', 'pageview');
</script>

<script type="text/javascript"> 
/*<![CDATA[*/ 
(function() { 
var sz = document.createElement('script'); sz.type = 'text/javascript'; sz.async = true; 
sz.src = '//siteimproveanalytics.com/js/siteanalyze_59840.js'; 
var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(sz, s); 
})(); 
/*]]>*/ 
</script>




<script>
  function myFunction() {
    var x = document.getElementById("myTopnav");
    if (x.className === "topnav") {
      x.className += " responsive";
    } else {
      x.className = "topnav";
    }
  }
  </script>
  
  
  <script>
  

function openSubscribeModal() {
console.log('openSubscribeModal')
  var m = document.getElementById('subscribe-modal');
  m.style.visibility = 'visible';
  m.style.display = 'block';
  }
  
  function closeSubscriptionModal() {
    var m = document.getElementById('subscribe-modal');
  m.style.visibility = 'hidden';
  m.style.display = 'none';
  }

  </script>
  

</body>
</html>




